RankAlpha logo
Back to Rankings

REGN

RegeneronC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
REGN vs peer average
39/100
REGN vs. peer average (C vs. B)
Grade spread
A 3 · B 2 · C 4 · D 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AMGN is the first available peer comparator.

Broad large-cap biotech comparator from the packet, not a direct retina-franchise peer. It is mainly useful for comparing how investors value mature biologics cash flow, pipeline reinvestment, and capital returns across diversified biotech models.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAMGNAmgen
REGN
Regeneron
AMGN
Amgen
Grade
C
C
Momentum
13
36
Value
66
64
Sentiment
77
47
Setup Bias
Net Bearish
-
Market Cap
-
-
Posture
Mixed
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs AMGN

REGN / AMGN
Grade Position
Below peers
REGN vs. peer average (C vs. B)
39/100
Momentum
13
AMGN
Value
66
REGN
Sentiment
77
REGN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs REGN
1
AMGN
AMGN
C
60/100
Even
2
ALNY
ALNY
B
80/100
-1
3
GILD
GILD
C
60/100
Even
4
ARGX
argenx SE ADR
A
100/100
-2
5
TAK
Takeda Pharmaceutical Co Ltd ADR
C
60/100
Even
AMGN is the first peer returned for this comparison set.